Feasibility of Risk Assessment for Type 2 Diabetes in Community Pharmacies Using Two Different Approaches: A Pilot Study in Thailand
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32870
Feasibility of Risk Assessment for Type 2 Diabetes in Community Pharmacies Using Two Different Approaches: A Pilot Study in Thailand

Authors: Thitaporn Thoopputra, Tipaporn Pongmesa, Shuchuen Li


Aims: To evaluate the application of non-invasive diabetes risk assessment tool in community pharmacy setting. Methods: Thai diabetes risk score was applied to assess individuals at risk of developing type 2 diabetes. Interactive computer-based risk screening (IT) and paper-based risk screening (PT) tools were applied. Participants aged over 25 years with no known diabetes were recruited in six participating pharmacies. Results: A total of 187 clients, mean aged (+SD) was 48.6 (+10.9) years. 35% were at high risk. The mean value of willingness-to-pay for the service fee in IT group was significantly higher than PT group (p=0.013). No significant difference observed for the satisfaction between groups. Conclusions: Non-invasive risk assessment tool, whether paper-based or computerized-based can be applied in community pharmacy to support the enhancing role of pharmacists in chronic disease management. Long term follow up is needed to determine the impact of its application in clinical, humanistic and economic outcomes.

Keywords: Community pharmacy, intervention, prevention, risk assessment, type 2 diabetes.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1088624

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 2165


[1] Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4-14.
[2] Aekplakorn W, Stolk RP, Neal B, Suriyawongpaisal P, Chongsuvivatwong V, Cheepudomwit S, et al. The Prevalence and Management of Diabetes in Thai Adults. Diabetes Care. 2003;26(10):2758-63.
[3] Absetz P, Oldenburg B, Hankonen N, Valve R, Heinonen H, Nissinen A, et al. Type 2 diabetes prevention in the real world: Three-year results of the goal lifestyle implementation trial. Diabetes Care. 2009;32(8):1418- 20.
[4] Harris M, Klein R, Welborn TA, Knuiman M. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care. 1992;15:815- 9.
[5] American Diabetes Association. Screening for Diabetes. Diabetes Care. 2002;25(supplement 1):S21-S4.
[6] Thoopputra T, Newby D, Schneider J, Li SC. Survey of diabetes risk assessment tools: concepts, structure and performance. Diabetes Metab Res Rev. 2012;28(6):485-98.
[7] Sudchada P, Khom-ar-wut C, Eaimsongchram A, Katemut S, Kunmaturos P, Deoisares R. Diabetes and cardiovascular risk factor controls in Thai type 2 diabetes with no history of cardiovascular complications; situation and compliance to diabetes management guideline in Thailand. J Diabetes Complicat. 2012;26(2):102-6.
[8] Ambady R, Chamukuttan S. Early diagnosis and prevention of diabetes in developing countries. Rev Endocr Metab Disord. 2008;9(3):193-201.
[9] Hourihan F, Krass I, Chen T. Health promotion and screening for cardiovascular risk factors in NSW: a community pharmacy model. Health Promot J Austr. 2003;14(2):101-7.
[10] Krass I, Mitchell B, Clarke P, Brillant M, Dienaar R, Hughes J, et al. Pharmacy diabetes care program: Analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy. Diabetes Res Clin Pract. 2007;75(3):339-47.
[11] Hersbergerm KE, Botomino A, Mancini M, Bruppacher R. Sequential screening for diabetes—evaluation of a campaign in Swiss community pharmacies. Pharm World Sci. 2006;28:171–9.
[12] Zhang YL, Gao WG, Pang ZC, Sun JP, Wang SJ, Ning F, et al. Diabetes self-risk assessment questionnaires coupled with a multimedia health promotion campaign are cheap and effective tools to increase public awareness of diabetes in a large Chinese population. Diabetic Med. 2012;29(11):e425-e9.
[13] Dhippayom T, Fuangchan A, Tunpichart S, Chaiyakunapruk N. Opportunistic screening and health promotion for type 2 diabetes: an expanding public health role for the community pharmacist. J Public Health(Oxf). 2012 September 12.(Epub ahead of print)
[14] Holmberg C, Harttig U, Schulze MB, Boeing H. The potential of the Internet for health communication: the use of an interactive on-line tool for diabetes risk prediction. Patient Educ Couns. 2011 Apr;83(1):106-12.
[15] Bader JL, Strickman-Stein N. Evaluation of new multimedia formats for cancer communications. J Med Internet Res. 2003 Jul-Sep;5(3):e16.
[16] Baehring TU, Schulze H, Bornstein SR, Scherbaum WA. Using the World Wide Web - A new approach to risk identification of diabetes mellitus. Int J Med Inform. 1997;46(1):31-9.
[17] Health information system development office. Thai diabetes risk assessment. Bangkok,2010. Available from: http://www.hiso.or.th/hiso /teachnology/teachnology1_2.php.Last accessed 14 February 2013.
[18] Department of Health and Aging, Australian Government. Diabetes risk assessment tool. 2010. Available from http://www.health.gov.au/ internet/main/publishing.nsf/Content/diabetesRiskAssessmentTool.Last accessed 14 February 2013.
[19] Litwin MS. How to measure survey reliability and validity. CA: SAGE; 1995.
[20] George Institute for International Health. Asia-Pacific Has The Biggest Diabetes Burden In The World.2007. Available from: http://www.sciencedaily.com /releases/2007/02/070228123353.htm. Last accessed 24 February 2013.
[21] Chatterjee S, Riewpaiboon A, Piyauthakit P, Riewpaiboon W, Boupaijit K, Panpuwong N, et al. Cost of diabetes and its complications in Thailand: a complete picture of economic burden. Health Soc Care Community. 2011 May;19(3):289-98.
[22] Lipkus IM, Hollands JG. The visual communication of risk. J Natl Cancer Inst Monogr. 1999(25):149-63.
[23] Ribu L, Hanestad B, Moum T, Birkeland K, Rustoen T. A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Quality of Life Res. 2007;16(2):179-89.
[24] Grandy S, Fox K. EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Health and Quality of Life Outcomes. 2008;6(1):18.
[25] Sookaneknun P, Saramunee K, Rattarom R, Kongsri S, Senanok R, Pinitkit P, et al. Economic analysis of the diabetes and hypertension screening collaboration between community pharmacies and a Thai government primary care unit. Prim Care Diabetes. 2010 Oct;4(3):155- 64.
[26] Silaruks B, Limwattananon C, Limwattananon S, Boonkaw P. Community participation in diabetes risk screening service: in the context of primary care unit. Thai J Hosp Pharm. 2008;18(1):52-62.